Project Grant K23AG086604
Award Date
9/10/24
Completion Date
6/30/29
Dollars Obligated
$360K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27514, USA
Similar Awards
The National Institutes of Health's National Cancer Institute awarded $331,085.91 under the Cancer Research Manpower federal grant program (CFDA 93.398) to Brigham & Women's Hospital Inc. on February 1, 2021 for completion by September 30, 2022. The project grant funding will support research investigating the role of cellular senescence in chemotherapy-related cognitive impairment and the contribution of microglia to chemotherapy-induced senescence in the brain. Specifically, the grantee...
This Project Grant award from the National Institute on Aging's (NIA) Aging Research program (CFDA 93.866) totaling $1,832,910 will fund a multi-center clinical trial to investigate the effects of partnered adapted Argentine tango dance on sensory symptoms, functional restoration, and underlying mechanisms in 140 breast cancer survivors with chemotherapy-induced neuropathy. The trial, titled "DANCE-BASED AVENUES TO ADVANCE NONPHARMACOLOGIC TREATMENT OF CHEMOTHERAPY EFFECTS (DAANCE)",...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will provide $168,775.00 to the University of Connecticut Health Center to conduct a randomized, two-arm, clinical trial pilot study on the use of a neuroplasticity-based computerized cognitive remediation (CCR) intervention for treating post-viral neurocognitive dysfunction (PND) in older adults. The key objectives are to: 1) examine the preliminary efficacy of CCR for improving cognitive performance...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $624,000.00 to the University of Texas Health Science Center at Houston to explore a patient priorities care framework for improving breast cancer survivorship care for older women with multiple chronic conditions. The project aims to use this framework to identify patient priorities, incorporate them into treatment plans, and evaluate the feasibility and impact on treatment burden and quality...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) provides $135,513 to Beth Israel Deaconess Medical Center, Inc. (BIDMC) to conduct research on the transcriptional mechanisms underlying chemotherapy-induced cognitive impairment in cancer survivors. The research aims to elucidate the transcriptional regulation governing brain cell disturbances, such as neuronal death and activated microglia, that contribute to this debilitating side effect of...
This Cooperative Agreement award, valued at $294,787, was made by the National Cancer Institute (NCI) under the Cancer Treatment Research (CFDA 93.395) program. The award supports the planning and development of a virtual exercise intervention trial aimed at preventing functional decline in cancer patients undergoing chemotherapy. Key components include: Assessing factors associated with functional decline in cancer survivors enrolled in the American Cancer Society Cancer Prevention Study-3...
The National Cancer Institute (NCI), under the Federal Grant Program for Cancer Research Manpower (CFDA 93.398), awarded a $135,990 Project Grant to the University of Illinois in Chicago to conduct research on cognition, vascular function, and physical activity in colorectal cancer survivors. The 1.5-year study, beginning January 17, 2025, aims to: (1) compare cognitive processing speed, arterial stiffness, and moderate-to-vigorous physical activity levels between colorectal cancer survivors and...
This Project Grant award of $700,049 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will fund a study on the impact of targeted tyrosine kinase inhibitor (TKI) therapies on cancer-related cognitive impairment (CRCI) among patients with chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). The study, led by the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, will recruit 200 patients about to begin TKI treatment for CML or CLL,...
The federal Project Grant award R01CA299480, titled "The MIND-BC Study: MIND Diet for Breast Cancer Cognition", is being provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393). The $713,235 award will fund a randomized controlled trial to evaluate the efficacy of the MIND diet in improving cognitive functioning among breast cancer survivors who have completed adjuvant treatment within the past 3 years and are reporting...